David F Burgstahler Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David F Burgstahler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David F Burgstahler. David F Burgstahler is a Director in ANGIODYNAMICS INC ($ANGO) and a Director in Warner Chilcott plc ($WCRX) and a Director in Lantheus Holdings, Inc. ($LNTH) and a in INC Research Holdings, Inc. ($INCR) and a Director in INC Research Holdings, Inc. ($INCR) and a President & CEO in Organogenesis Holdings Inc. ($AHPA) and a Director in WideOpenWest, Inc. ($WOW) and a Director in Osmotica Pharmaceuticals plc ($OSMT).
Address: AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK 10022 NY
Companies in which David F Burgstahler is an Insider
ANGIODYNAMICS INC
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of David F Burgstahler: Director
Holdings: 1,446,413 shares
Current Value: $23,460,819
Latest Transaction: Apr 14 2017
$ANGO Market Capitalization: $588.81M
$ANGO Previous Close: $16.22
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lantheus Holdings, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of David F Burgstahler: Director
Holdings: 247,253 shares
Current Value: $2,225,277
Latest Transaction: Sep 11 2017
$LNTH Market Capitalization: $323.30M
$LNTH Previous Close: $9.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Organogenesis Holdings Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David F Burgstahler: President & CEO
Holdings: 9,022,741 shares
Current Value: $89,144,681
Latest Transaction: Dec 12 2018
$ORGO Market Capitalization: $74.25M
$ORGO Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Osmotica Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David F Burgstahler: Director
Holdings: 0 shares
Latest Transaction: Nov 23 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syneos Health, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of David F Burgstahler: Director
Holdings: 38,758 shares
Current Value: $2,054,174
Latest Transaction: May 24 2017
$INCR Market Capitalization: $2.83B
$INCR Previous Close: $53.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Warner Chilcott plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David F Burgstahler: Director
Holdings: 20,000 shares
Latest Transaction: May 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WideOpenWest, Inc.
Industry: CABLE & OTHER PAY TELEVISION SERVICES [4841]
Position of David F Burgstahler: Director
Holdings: 31,654 shares
Latest Transaction: Jan 10 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David F Burgstahler
Sentiment: All, ANGO, LNTH, ORGO, OSMT, INCR, WCRX, WOW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 23 2020 | OSMT | Osmotica Pharmaceu ... | Burgstahler David F | Director | Sell | J | 0.00 | 4,936,926 | 0 | 0 | 4.9 M to 0 (-100.00 %) |
| Jan 15 2020 | OSMT | Osmotica Pharmaceu ... | Burgstahler David F | Director | Buy | P | 5.00 | 1,250,000 | 6,250,000 | 15,730,864 | 14.5 M to 15.7 M (+8.63 %) |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | A | 0.00 | 4,100,000 | 0 | 4,100,000 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | D | 0.00 | 3,247,668 | 0 | 1,048,691 | |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 6,538,732 | 0 | 15,561,473 | 9 M to 15.6 M (+72.47 %) |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Grant | A | 0.00 | 9,022,741 | 0 | 9,022,741 | 0 to 9 M |
| Dec 12 2018 | AHPA | Organogenesis Hold ... | Burgstahler David F | President & CEO | Option Exercise | A | 0.00 | 4,100,000 | 0 | 4,100,000 |